| |
| |
|
| Insider
Information: |
Toole John J |
| Relationship: |
SVP, Clinical Research |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
19,600 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,252,048 |
|
|
| Total
Shares |
19,600 |
|
|
| Total
Value |
$1,252,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
SVP, Clinical Research |
2007-04-25 |
0 |
2007-04-25 |
19,600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-08-16 |
4 |
S |
$63.60 |
$3,171,768 |
D/D |
(49,800) |
13,751 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-08-16 |
4 |
OE |
$7.40 |
$427,801 |
D/D |
50,000 |
63,551 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-11-17 |
4 |
S |
$68.89 |
$2,504,710 |
D/D |
(36,328) |
12,839 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-11-17 |
4 |
OE |
$9.34 |
$361,399 |
D/D |
36,528 |
49,367 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-11-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
4,034 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-12-20 |
4/A |
OE |
$7.40 |
$29,594 |
D/D |
4,000 |
16,839 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2006-12-20 |
4 |
OE |
$7.40 |
$29,594 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-23 |
4 |
S |
$73.23 |
$1,465,430 |
D/D |
(20,000) |
16,839 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-23 |
4 |
OE |
$13.60 |
$272,050 |
D/D |
20,000 |
36,839 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,839 |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-02-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
16,839 |
20,873 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-04-25 |
4 |
S |
$83.05 |
$1,590,903 |
D/D |
(19,148) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Clinical Research |
• – – |
2007-04-25 |
4 |
OE |
$13.60 |
$260,461 |
D/D |
19,148 |
19,148 |
0 |
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
